Showing 1,041 - 1,060 results of 33,734 for search '(( 2 fold decrease ) OR ( 50 ((((nn decrease) OR (we decrease))) OR (a decrease)) ))', query time: 0.98s Refine Results
  1. 1041

    Comparison of fold changes in off-rate for gD as a function of protein length (306t vs. 285t). by Tina M. Cairns (4110190)

    Published 2017
    “…Protein length was tested in the context of both gD1 (A) and gD2 (B). Bars are colored to highlight greater than 5-fold change in rates as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1006430#ppat.1006430.g007" target="_blank">Fig 7</a>. …”
  2. 1042

    Coupled Protein Diffusion and Folding in the Cell by Minghao Guo (667684)

    Published 2014
    “…The resulting region-dependent anomalous diffusion is well characterized by 2-D or 3-D diffusion equations coupled to a clustering algorithm that accounts for position-dependent diffusion. …”
  3. 1043
  4. 1044
  5. 1045
  6. 1046
  7. 1047
  8. 1048
  9. 1049
  10. 1050
  11. 1051
  12. 1052
  13. 1053
  14. 1054
  15. 1055

    Data_Sheet_1_Applying the Toyota production system to decrease the time required to transport patients undergoing surgery from the general ward to the operating room and reviewing... by Chien-Chung Lin (244489)

    Published 2022
    “…The time spent on elevator transport decreased by 44.4%. We developed a process for future use based on information-assisted patient and staff identification. …”
  16. 1056

    Data_Sheet_2_Applying the Toyota production system to decrease the time required to transport patients undergoing surgery from the general ward to the operating room and reviewing... by Chien-Chung Lin (244489)

    Published 2022
    “…The time spent on elevator transport decreased by 44.4%. We developed a process for future use based on information-assisted patient and staff identification. …”
  17. 1057

    AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

    Published 2018
    “…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. …”
  18. 1058

    The numerical values underlying Fig 4. by Wataru Matsunaga (3452621)

    Published 2023
    “…However, only the KO mice showed a significant decrease in rotarod performance of 1.2 g/kg EtOH. …”
  19. 1059

    Fig 2 - by Byunghun So (12036995)

    Published 2022
    “…<p>2D-PAGE images and Venn diagram showing differential protein expression (>2-fold) between CON and HFD groups (A-D). …”
  20. 1060